Comparing Cetuximab vs Erbitux
Cetuximab | Erbitux (cetuximab) |
|
---|
Cetuximab | Erbitux (cetuximab) |
|
|||||||
---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Squamous Cell Carcinoma, Head and Neck Cancer, Colorectal Cancer, Non Small Cell Lung Cancer, Pancreatic Cancer. Cetuximab may also be used for purposes not listed in this medication guide. View more |
Prescription only
Prescribed for Squamous Cell Carcinoma, Head and Neck Cancer, Colorectal Cancer. Erbitux may also be used for purposes not listed in this medication guide. |
Related suggestions Colorectal Cancer
Squamous Cell Carcinoma
|
|||||||
More about Cetuximab | More about Erbitux (cetuximab) | ||||||||
Ratings & Reviews | |||||||||
Cetuximab has an average rating of 7.1 out of 10 from a total of 10 ratings on Drugs.com. 50% of reviewers reported a positive effect, while 10% reported a negative effect. |
Erbitux has an average rating of 6.9 out of 10 from a total of 9 ratings on Drugs.com. 44% of reviewers reported a positive effect, while 11% reported a negative effect. |
||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
View all Cetuximab side effects |
View all Erbitux side effects |
||||||||
Drug Class | |||||||||
Generic Availability | |||||||||
N/A |
N/A |
||||||||
Pricing and Coupons * Prices are without insurance | |||||||||
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Erbitux prices |
||||||||
Dosage Forms | |||||||||
N/A |
|
||||||||
Brand Names | |||||||||
Erbitux |
N/A |
||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
213 hours |
213 hours |
||||||||
CSA Schedule 1 View glossary of CSA terms | |||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
Pregnancy Category | |||||||||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||
Drug Interactions | |||||||||
A total of 23 drugs are known to interact with Cetuximab:
|
A total of 23 drugs are known to interact with Erbitux:
|
||||||||
Alcohol/Food/Lifestyle Interactions | |||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
Disease Interactions | |||||||||
First Approval Date | |||||||||
N/A |
February 12, 2004 |
||||||||
WADA Class View classifications | |||||||||
N/A |
N/A |
||||||||
More Information | |||||||||
Patient Resources | |||||||||
Professional Resources | |||||||||
Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Keytruda
Keytruda is used to treat melanoma, non-small cell lung cancer, malignant pleural mesothelioma ...
Opdivo
Opdivo is used to treat many cancers, such as melanoma, non-small cell lung cancer, malignant ...
Opdivo Qvantig
Opdivo Qvantig is used to treat adults with melanoma, non-small cell lung cancer, renal cell ...
Libtayo
Libtayo (cemiplimab-rwlc) is used to treat metastatic cutaneous squamous cell carcinoma, basal cell ...
Erbitux
Erbitux (cetuximab) is used to treat cancers of the colon and rectum. Learn about side effects ...
Blenoxane
Blenoxane is used for hodgkin's lymphoma, non-hodgkin's lymphoma, squamous cell carcinoma ...
Unloxcyt
Unloxcyt (cosibelimab-ipdl) is an anti-PD-1 treatment for metastatic or advanced cutaneous squamous ...
Cemiplimab
Cemiplimab is used for basal cell carcinoma, non small cell lung cancer, squamous cell carcinoma
Bleomycin
Bleomycin is used for hodgkin's lymphoma, malignant pleural effusion, non-hodgkin's lymphoma ...
Pembrolizumab
Pembrolizumab (Keytruda) is a monoclonal antibody cancer medicine used to treat
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.